Lipid-based nanosystem of edaravone: development, optimization, characterization and in vitro/in vivo evaluation

References

• Ali Khan A, Mudassir J, Mohtar N, Darwis Y. (2013). Advanced drug delivery to the lymphatic system: lipid-based nanoformulations. Int J Nanomed 8:2733–44.
   PubMed Web of Science ®Google Scholar
• Anonymous. (2010). Capryol™ PGMC Gattefossé.
   Google Scholar
• Anonymous. (2012). Powder Flow. The United States Pharmacopeial Convention, United States, 801–4.
   Google Scholar
• Anonymous. (2015a). Orphan Drug Designations and Approvals. U.S. Food and Drug Administration, Maryland, USA.
   Google Scholar
• Anonymous. (2015b). Public summary of opinion on orphan designation: Edaravone for the treatment of amyotrophic lateral sclerosis. European Medicines Agency, London, United Kingdom.
   Google Scholar
• Atwood CS, Perry G, Zeng H, et al. (2004). Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta. Biochemistry 43:560–8.
   PubMed Web of Science ®Google Scholar
• Bala V, Rao S, Bateman E, et al. (2016). Enabling oral SN38-based chemotherapy with a combined lipophilic prodrug and self-microemulsifying drug delivery system. Mol Pharm 13:3518–25.
   Google Scholar
• Balakrishnan P, Lee BJ, Oh DH, et al. (2009). Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems. Int J Pharm 374:66–72.
   PubMed Web of Science ®Google Scholar
• Bi X, Liu X, Di L, Zu Q. (2016). Improved oral bioavailability using a solid self-microemulsifying drug delivery system containing a multicomponent mixture extracted from salvia miltiorrhiza. Molecules 21:456.
   PubMed Web of Science ®Google Scholar
• Borges RS, Queiroz AN, Mendes AP, et al. (2012). Density functional theory (DFT) study of edaravone derivatives as antioxidants. IJMS 13:7594–606.
   Web of Science ®Google Scholar
• Borhade V, Nair H, Hegde D. (2008). Design and evaluation of self-microemulsifying drug delivery system (SMEDDS) of tacrolimus. AAPS PharmSciTech 9:13–21.
   PubMed Web of Science ®Google Scholar
• Cerpnjak K, Zvonar A, Vrecer F, Gasperlin M. (2015). Characterization of naproxen-loaded solid SMEDDSs prepared by spray drying: the effect of the polysaccharide carrier and naproxen concentration. Int J Pharm 485:215–28.
   PubMed Web of Science ®Google Scholar
• Christiansen A, Backensfeld T, Denner K, Weitschies W. (2011). Effects of non-ionic surfactants on cytochrome P450-mediated metabolism in vitro. Eur J Pharm Biopharm 78:166–72.
   PubMed Web of Science ®Google Scholar
• Cirri M, Mura P, Mora PC. (2007). Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems. Int J Pharm 340:84–91.
   PubMed Web of Science ®Google Scholar
• Collnot EM, Baldes C, Wempe MF, et al. (2007). Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity. Mol Pharm 4:465–74.
   PubMed Web of Science ®Google Scholar
• Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci 13:123–33.
   PubMed Web of Science ®Google Scholar
• Dangre P, Gilhotra R, Dhole S. (2016). Formulation and statistical optimization of self-microemulsifying drug delivery system of eprosartan mesylate for improvement of oral bioavailability. Drug Deliv Transl Res 6:610–21.
   PubMed Web of Science ®Google Scholar
• Deshmukh A, Kulkarni S. (2014). Solid self-microemulsifying drug delivery system of ritonavir. Drug Dev Ind Pharm 40:477–87.
   PubMed Web of Science ®Google Scholar
• Dixit AR, Rajput SJ, Patel SG. (2010). Preparation and bioavailability assessment of SMEDDS containing valsartan. AAPS PharmSciTech 11:314–21.
   PubMed Web of Science ®Google Scholar
• Dokania S, Joshi AK. (2015). Self-microemulsifying drug delivery system (SMEDDS)-challenges and road ahead. Drug Deliv 22:675–90.
   PubMed Web of Science ®Google Scholar
• Grill AE, Koniar B, Panyam J. (2014). Co-delivery of natural metabolic inhibitors in a self-microemulsifying drug delivery system for improved oral bioavailability of curcumin. Drug Deliv Transl Res 4:344–52.
   PubMed Web of Science ®Google Scholar
• Grove M, Mullertz A, Nielsen JL, Pedersen GP. (2006). Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides. Eur J Pharm Sci 28:233–42.
   PubMed Web of Science ®Google Scholar
• Gupta S, Kesarla R, Omri A. (2013). Formulation strategies to improve the bioavailability of poorly absorbed drugs with special emphasis on self-emulsifying systems. ISRN Pharm 2013:848043.
   PubMedGoogle Scholar
• Hayashi T, Mori T, Sohmiya K, et al. (2003). Efficacy of edaravone, a free radical scavenger, on left ventricular function and structure in diabetes mellitus. J Cardiovasc Pharm 41:923–9.
   PubMed Web of Science ®Google Scholar
• Hoosain FG, Choonara YE, Tomar LK, et al. (2015). Bypassing P-glycoprotein drug efflux mechanisms: possible applications in pharmacoresistant schizophrenia therapy. BioMed Res Int 2015:484963.
   PubMed Web of Science ®Google Scholar
• Hudson JS, Hoyne DS, Hasan DM. (2013). Inflammation and human cerebral aneurysms: current and future treatment prospects. Future Neurol 8:1–16.
   Google Scholar
• Ilem-Ozdemir D, Gundogdu E, Ekinci M, et al. (2015). Comparative permeability studies with radioactive and nonradioactive risedronate sodium from self-microemulsifying drug delivery system and solution. Drug Dev Ind Pharm 41:1493–8.
   PubMed Web of Science ®Google Scholar
• Ishak RA, Osman R. (2015). Lecithin/TPGS-based spray-dried self-microemulsifying drug delivery systems: in vitro pulmonary deposition and cytotoxicity. Int J Pharm 485:249–60.
   PubMed Web of Science ®Google Scholar
• Jain AK, Thanki K, Jain S. (2014). Solidified self-nanoemulsifying formulation for oral delivery of combinatorial therapeutic regimen: part I. Formulation development, statistical optimization, and in vitro characterization. Pharm Res 31:923–45.
   PubMed Web of Science ®Google Scholar
• Jaiswal P, Aggarwal G, Harikumar SL, Singh K. (2014). Development of self-microemulsifying drug delivery system and solid-self-microemulsifying drug delivery system of telmisartan. Int J Pharma Investig 4:195–2016.
   PubMedGoogle Scholar
• Jian Zenga YR, Zhoua C, Yua S, Chenb W-H. (2010). Preparation and physicochemical characteristics of the complex of edaravone with hydroxypropyl–cyclodextrin. Carbohydrate Polym 83:5.
   Web of Science ®Google Scholar
• Jiao SS, Yao XQ, Liu YH, et al. (2015). Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits. Proc Natl Acad Sci USA 112:5225–30.
   PubMed Web of Science ®Google Scholar
• Kamboj S, Rana V. (2016). Quality-by-design based development of a self-microemulsifying drug delivery system to reduce the effect of food on Nelfinavir mesylate. Int J Pharm 501:311–25.
   PubMed Web of Science ®Google Scholar
• Kanaujia P, Ng WK, Tan RB. (2014). Solid self-emulsifying drug delivery system (S-SEDDS) for improved dissolution rate of fenofibrate. J Microencapsulat 31:293–8.
   PubMed Web of Science ®Google Scholar
• Kikuchi K, Takeshige N, Miura N, et al. (2012). Beyond free radical scavenging: beneficial effects of edaravone (Radicut) in various diseases (Review). Exp Therapeut Med 3:3–8.
   PubMed Web of Science ®Google Scholar
• Kikuchi K, Uchikado H, Miyagi N, et al. (2011). Beyond neurological disease: new targets for edaravone (review). Int J Mol Med 28:899–906.
   PubMed Web of Science ®Google Scholar
• Kim GG, Poudel BK, Marasini N, et al. (2013). Enhancement of oral bioavailability of fenofibrate by solid self-microemulsifying drug delivery systems. Drug Dev Ind Pharm 39:1431–8.
   PubMed Web of Science ®Google Scholar
• Krstic M, Popovic M, Dobricic V, Ibric S. (2015). Influence of solid drug delivery system formulation on poorly water-soluble drug dissolution and permeability. Molecules 20:14684–98.
   PubMed Web of Science ®Google Scholar
• Kuntsche J, Horst JC, Bunjes H. (2011). Cryogenic transmission electron microscopy (cryo-TEM) for studying the morphology of colloidal drug delivery systems. Int J Pharm 417:120–37.
   PubMed Web of Science ®Google Scholar
• Laddha P, Suthar V, Butani S. (2014). Development and optimization of self microemulsifying drug delivery of domperidone. Braz J Pharm Sci 50:10.
   Web of Science ®Google Scholar
• Lapchak PA. (2010). A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy? Exp Opin Pharmacother 11:1753–63.
   PubMed Web of Science ®Google Scholar
• Pham-Huy LA, He H, Pham-Huy C. (2008). Free radicals, antioxidants in disease and health. Int J Biomed Sci 4:89–96.
   PubMedGoogle Scholar
• Lim SM, Pang ZW, Tan HY, et al. (2015). Enhancement of docetaxel solubility using binary and ternary solid dispersion systems. Drug Dev Ind Pharm 41:1847–55.
   PubMed Web of Science ®Google Scholar
• Ma L, Sun J, Peng Y, et al. (2012). Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform. Drug Metab Dispos 40:734–41.
   PubMed Web of Science ®Google Scholar
• Mayes J, Tinker-Mill C, Kolosov O, et al. (2014). beta-amyloid fibrils in Alzheimer disease are not inert when bound to copper ions but can degrade hydrogen peroxide and generate reactive oxygen species. J Biol Chem 289:12052–62.
   PubMed Web of Science ®Google Scholar
• Mi Y, Zhao J, Feng SS. (2012). Vitamin E TPGS prodrug micelles for hydrophilic drug delivery with neuroprotective effects. Int J Pharm 438:98–106.
   PubMed Web of Science ®Google Scholar
• Milton NG. (2004). Role of hydrogen peroxide in the aetiology of Alzheimer's disease: implications for treatment. Drugs Aging 21:81–100.
   PubMed Web of Science ®Google Scholar
• Sinha MK, Anuradha HK, Juyal R, Shukla R, et al. (2009). Edaravone in acute ischemic stroke, an Indian experience. Neurol Asia 14:7–10.
   Web of Science ®Google Scholar
• Mohsin K, Alamri R, Ahmad A, et al. (2016). Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug. Int J Nanomed 11:2829–38.
   PubMed Web of Science ®Google Scholar
• Rao MRP, Munjapara GS, Khole IA. (2011). Preparation and evaluation of self-microemulsifying drug delivery system of carvedilol. Latin Am J Pharm 30:837–43.
   Web of Science ®Google Scholar
• Nakajima N, Watanabe S, Kiyoi T, et al. (2015). Evaluation of edaravone against radiation-induced oral mucositis in mice. J Pharmacol Sci 127:339–43.
   PubMed Web of Science ®Google Scholar
• Oh DH, Kang JH, Kim DW, et al. (2011). Comparison of solid self-microemulsifying drug delivery system (solid SMEDDS) prepared with hydrophilic and hydrophobic solid carrier. Int J Pharm 420:412–18.
   PubMed Web of Science ®Google Scholar
• Parikh A, Kathawala K, Tan CC, et al. (2016). Development of a novel oral delivery system of edaravone for enhancing bioavailability. Int J Pharm 515:490–500.
   PubMed Web of Science ®Google Scholar
• Prasad YV, Puthli SP, Eaimtrakarn S, et al. (2003). Enhanced intestinal absorption of vancomycin with Labrasol and D-alpha-tocopheryl PEG 1000 succinate in rats. Int J Pharm 250:181–90.
   PubMed Web of Science ®Google Scholar
• Rahman K. (2007). Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging 2:219–36.
   PubMed Web of Science ®Google Scholar
• Rong WT, Lu YP, Tao Q, et al. (2014). Hydroxypropyl–sulfobutyl-beta-cyclodextrin improves the oral bioavailability of edaravone by modulating drug efflux pump of enterocytes. J Pharm Sci 103:730–42.
   PubMed Web of Science ®Google Scholar
• Rowe R, Sheskey P, Quinn M. (2009). Handbook of pharmaceutical excipient. UK and USA: Pharmaceutical Press and American Pharmacists Association, 1–917.
   Google Scholar
• Sallam MA, Marin Bosca MT. (2015). Optimization, ex vivo permeation, and stability study of lipid nanocarrier loaded gelatin capsules for treatment of intermittent claudication. Int J Nanomed 10:4459–78.
   PubMed Web of Science ®Google Scholar
• Kalepu S, Manthina M, Padavala V. (2013). Oral lipid-based drug delivery systems – an overview. Acta Pharm Sinica B 3:361–72.
   Web of Science ®Google Scholar
• Shafiq-un-Nabi S, Shakeel F, Talegaonkar S, et al. (2007). Formulation development and optimization using nanoemulsion technique: a technical note. AAPS PharmSciTech 8:E1–6.
   PubMed Web of Science ®Google Scholar
• Singh AK, Chaurasiya A, Awasthi A, et al. (2009). Oral bioavailability enhancement of exemestane from self-microemulsifying drug delivery system (SMEDDS). AAPS PharmSciTech 10:906–16.
   PubMed Web of Science ®Google Scholar
• Singh AK, Chaurasiya A, Singh M, et al. (2008). Exemestane loaded self-microemulsifying drug delivery system (SMEDDS): development and optimization. AAPS PharmSciTech 9:628–34.
   PubMed Web of Science ®Google Scholar
• Park S-E, Nho Y-C, Lim Y-M, Kim H-I. (2003). Preparation of pH-sensitive poly(vinyl alcohol-g-methacrylic acid) and poly(vinyl alcohol-g-acrylic acid) hydrogels by gamma ray irradiation and their insulin release behavior. J Appl Polym Sci 91:636–43.
   Web of Science ®Google Scholar
• Valko M, Leibfritz D, Moncol J, et al. (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44–84.
   PubMed Web of Science ®Google Scholar
• Verma A, Singh MK, Kumar B. (2011). Development and characterization of flutamide containing self-microemulsifying drug delivery system (SMEDDS). Int J Pharm Pharm Sci 3:60–5.
   Google Scholar
• Wais U, Jackson AW, He T, Zhang H. (2016). Nanoformulation and encapsulation approaches for poorly water-soluble drug nanoparticles. Nanoscale 8:1746–69.
   PubMed Web of Science ®Google Scholar
• Wei L, Sun P, Nie S, Pan W. (2005). Preparation and evaluation of SEDDS and SMEDDS containing carvedilol. Drug Dev Ind Pharm 31:785–94.
   PubMed Web of Science ®Google Scholar
• Wu L, Qiao Y, Wang L, et al. (2015). A self-microemulsifying drug delivery system (SMEDDS) for a novel medicative compound against depression: a preparation and bioavailability study in rats. AAPS PharmSciTech 16:1051–8.
   PubMed Web of Science ®Google Scholar
• Yeom DW, Son HY, Kim JH, et al. (2016). Development of a solidified self-microemulsifying drug delivery system (S-SMEDDS) for atorvastatin calcium with improved dissolution and bioavailability. Int J Pharm 506:302–11.
   PubMed Web of Science ®Google Scholar
• Yeom DW, Song YS, Kim SR, et al. (2015). Development and optimization of a self-microemulsifying drug delivery system for atorvastatin calcium by using D-optimal mixture design. Int J Nanomed 10:3865–77.
   PubMed Web of Science ®Google Scholar
• Yi T, Tang D, Wang F, et al. (2017). Enhancing both oral bioavailability and brain penetration of puerarin using borneol in combination with preparation technologies. Drug Deliv 24:422–9.
   PubMed Web of Science ®Google Scholar
• Yoshino H, Kimura A. (2006). Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (phase II study). Amyotrophic Lateral Sclerosis 7:241–5.
   PubMed Web of Science ®Google Scholar
• Zhang P, Liu Y, Feng N, Xu J. (2008). Preparation and evaluation of self-microemulsifying drug delivery system of oridonin. Int J Pharm 355:269–76.
   PubMed Web of Science ®Google Scholar
• Zhang W, Li Y, Zou P, et al. (2016). The effects of pharmaceutical excipients on gastrointestinal tract metabolic enzymes and transporters—an update. AAPS J 18:830–43.
   PubMed Web of Science ®Google Scholar
• Zhang Y, He L, Yue S, et al. (2017). Characterization and evaluation of a self-microemulsifying drug delivery system containing tectorigenin, an isoflavone with low aqueous solubility and poor permeability. Drug Deliv 24:632–40.
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhou M, Yang FF, et al. (2015). Involvement of the inhibition of intestinal glucuronidation in enhancing the oral bioavailability of resveratrol by labrasol containing nanoemulsions. Mol Pharm 12:1084–95.
   PubMed Web of Science ®Google Scholar